Total properties:
10
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12496548
|
Filing Dt:
|
07/01/2009
|
Publication #:
|
|
Pub Dt:
|
02/25/2010
| | | | |
Title:
|
HEPARAN SULFATE INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
05/12/2015
|
Application #:
|
12649094
|
Filing Dt:
|
12/29/2009
|
Publication #:
|
|
Pub Dt:
|
07/22/2010
| | | | |
Title:
|
DETECTION OF OLIGOSACCHARIDES
|
|
|
Patent #:
|
|
Issue Dt:
|
07/31/2012
|
Application #:
|
12649110
|
Filing Dt:
|
12/29/2009
|
Publication #:
|
|
Pub Dt:
|
07/08/2010
| | | | |
Title:
|
QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12748948
|
Filing Dt:
|
03/29/2010
|
Publication #:
|
|
Pub Dt:
|
09/30/2010
| | | | |
Title:
|
GANGLIOSIDE BIOSYNTHESIS MODULATORS
|
|
|
Patent #:
|
|
Issue Dt:
|
05/22/2012
|
Application #:
|
13142925
|
Filing Dt:
|
09/01/2011
|
Publication #:
|
|
Pub Dt:
|
12/22/2011
| | | | |
Title:
|
POLYMER END GROUP DETECTION
|
|
|
Patent #:
|
|
Issue Dt:
|
11/26/2013
|
Application #:
|
13142959
|
Filing Dt:
|
09/01/2011
|
Publication #:
|
|
Pub Dt:
|
01/12/2012
| | | | |
Title:
|
DETECTION OF OLIGOSACCHARIDES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
13259099
|
Filing Dt:
|
12/12/2011
|
Publication #:
|
|
Pub Dt:
|
04/26/2012
| | | | |
Title:
|
N-LINKED GLYCAN BIOSYNTHESIS MODULATORS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
13519262
|
Filing Dt:
|
06/26/2012
|
Publication #:
|
|
Pub Dt:
|
11/22/2012
| | | | |
Title:
|
GLYCOSAMINOGLYCAN INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
07/08/2014
|
Application #:
|
13550106
|
Filing Dt:
|
07/16/2012
|
Publication #:
|
|
Pub Dt:
|
06/13/2013
| | | | |
Title:
|
METHODS OF DETERMINING THE PRESENCE AND/OR AMOUNT OF A BIOMARKER TO DETERMINE THE PRESENCE, IDENTITY, AND/OR SEVERITY OF A LYSOSOMAL STORAGE OR NEUROLOGICAL DISORDER
|
|
|
Patent #:
|
|
Issue Dt:
|
08/19/2014
|
Application #:
|
13629321
|
Filing Dt:
|
09/27/2012
|
Publication #:
|
|
Pub Dt:
|
08/22/2013
| | | | |
Title:
|
METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
|
|